MAPT and Alzheimer disease: We first determined tau levels in the preparations of these AD tau fractions by immuno‐dot blots developed with a mixture of pan‐tau rabbit polyclonal antibodies, R134d, 92e, and 111e, using recombinant tau441 (rTau441) as a standard (Figure 1D).